agilon health, inc.
Company Stats
- Market Cap
- $1.3B
- as of Sep 30, 2026
- Enterprise Value
- $1.2B
- Shares Outstanding
- 16.8M
- Free Float
- 97.5%
Income Statement
- Revenue
- $5.9B
- Operating Income
- -$463.2M
- Net Income
- -$391.3M
- EBITDA
- -$434.6M
- Non-cash Impairment
- $36.1M
- Revenue Growth, 3Y
- 35.4%
- FCF Margin, 3Y Avg
- -2.4%
- FCF Margin, Worst Year
- -4.0%
Cash Flow
- Free Cash Flow
- -$119.0M
- FCF Yield
- -8.9%
- Owner FCF Yield
- -12.6%
Balance Sheet
- Cash & Equivalents
- $173.7M
- Total Debt
- $35.0M
- Net Cash
- $138.7M
Returns & Capital
- Buyback Yield, 3Y Avg
- 5.0%
- SBC, 3Y Avg
- $56.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $5.9B | -$119.0M | -2.0% |
| FY2024 | $6.1B | -$71.0M | -1.2% |
| FY2023 | $4.3B | -$172.0M | -4.0% |
| FY2022 | $2.4B | -$146.2M | -6.1% |
| FY2021 | $1.5B | -$154.7M | -10.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges